1. Tanabe, Atsushi, Nakayama, Takatoshi, Kashiyanagi, Jo, Takemasa, Ichiro, Sahara, Hiroeki. 2022. YTHDC2 Promotes Malignant Phenotypes of Breast Cancer Cells. In Journal of oncology, 2022, 9188920. doi:10.1155/2022/9188920. https://pubmed.ncbi.nlm.nih.gov/36245989/
2. Qian, Baomei, Li, Yang, Yan, Ruoyu, Zhou, Jian, Ye, Lan. 2022. RNA binding protein RBM46 regulates mitotic-to-meiotic transition in spermatogenesis. In Science advances, 8, eabq2945. doi:10.1126/sciadv.abq2945. https://pubmed.ncbi.nlm.nih.gov/36001654/
3. Chen, Lu, Sun, Kangyue, Qin, Wenjie, Liu, Side, Zhang, Yue. 2023. LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation. In Cancer letters, 576, 216420. doi:10.1016/j.canlet.2023.216420. https://pubmed.ncbi.nlm.nih.gov/37778684/
4. Li, Qiang, Wang, Yaju, Meng, Xiangshu, Gao, Yu, Zhou, Lei. 2024. METTL16 inhibits papillary thyroid cancer tumorigenicity through m6A/YTHDC2/SCD1-regulated lipid metabolism. In Cellular and molecular life sciences : CMLS, 81, 81. doi:10.1007/s00018-024-05146-x. https://pubmed.ncbi.nlm.nih.gov/38334797/
5. Bailey, Alexis S, Fuller, Margaret T. 2024. YTHDC2 serves a distinct late role in spermatocytes during germ cell differentiation. In Proceedings of the National Academy of Sciences of the United States of America, 121, e2309548121. doi:10.1073/pnas.2309548121. https://pubmed.ncbi.nlm.nih.gov/39378093/
智鼠故事 
